[
    [
        {
            "time": "2023-10-05",
            "original_text": "Allergan (AGN) Gets FDA Approval for Migraine Drug Ubrelvy",
            "features": {
                "keywords": [
                    "Allergan",
                    "FDA Approval",
                    "Migraine Drug",
                    "Ubrelvy"
                ],
                "sentiment_score": 0.9,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "Allergan (AGN) Gets FDA Approval for Migraine Drug Ubrelvy",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "2023-10-05",
            "original_text": "Buy These 5 Low-Beta Stocks to Counter Market Volatility",
            "features": {
                "keywords": [
                    "Low-Beta Stocks",
                    "Market Volatility",
                    "Investment Strategy"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "general market"
                ],
                "causal_factor": "false",
                "causal_impact": "none",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "Buy These 5 Low-Beta Stocks to Counter Market Volatility",
                "Correlation": 4,
                "Sentiment": 6,
                "Importance": 5,
                "Impact": 4,
                "Duration": 3,
                "Entity_Density": 2,
                "Market_Scope": 7,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        }
    ]
]